Selected research
Industry Growth & Trends
Global Digital Therapeutics Platforms Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Digital Therapeutics Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Digital Therapeutics Platforms market include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Digital Therapeutics Platforms market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Digital Therapeutics Platforms market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital Therapeutics Platforms market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital Therapeutics Platforms.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Digital Therapeutics Platforms market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Digital Therapeutics Platforms Market by Company
Akili Interactive
DarioHealth
Teladoc Health
Voluntis
Sidekick Health
WellDoc
Talkspace
CogniFit
Tata Elxsi
Mahalo Health
2Morrow
Omada Health
Click Therapeutics
Orexo
ResMed
Virta Health
Bifourmis
SilverCloud (Amwell)
Noom
Big Health
Kaia Health
Cognoa
Headspace Health
CureApp
Calm Health
Riva Health
Sweetch-Health
Lark Health
Vida Health
Mahana Therapeutics
Blue Note Therapeutics
Lyra Health
Modern Health
Canary Health
Virgin Pulse
Slanhealth
Best Covered
Dami and Xiaomi
WeiMai
Jianhai Tech
Digital Therapeutics Platforms Segment by Type
Chronic Disease Digital Therapeutics
Psychiatric Disorders Digital Therapeutics
Quit Smoking Digital Therapeutics
Sleep Disorders and Respiratory Diseases Digital Therapeutics
Others
Digital Therapeutics Platforms Segment by Application
Enterprise
Personal
Digital Therapeutics Platforms Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Digital Therapeutics Platforms companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chronic Disease Digital Therapeutics
- Psychiatric Disorders Digital Therapeutics
- Quit Smoking Digital Therapeutics
- Sleep Disorders and Respiratory Diseases Digital Therapeutics
- Others
Applications
- Enterprise
- Personal
Companies covered
- Akili Interactive
- DarioHealth
- Teladoc Health
- Voluntis
- Sidekick Health
- WellDoc
- Talkspace
- CogniFit
- Tata Elxsi
- Mahalo Health
- 2Morrow
- Omada Health
- Click Therapeutics
- Orexo
- ResMed
- Virta Health
- Bifourmis
- SilverCloud (Amwell)
- Noom
- Big Health
- Kaia Health
- Cognoa
- Headspace Health
- CureApp
- Calm Health
- Riva Health
- Sweetch-Health
- Lark Health
- Vida Health
- Mahana Therapeutics
- Blue Note Therapeutics
- Lyra Health
- Modern Health
- Canary Health
- Virgin Pulse
- Slanhealth
- Best Covered
- Dami and Xiaomi
- WeiMai
- Jianhai Tech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Digital Therapeutics Platforms Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Digital Therapeutics Platforms Market Size by Region (2021-2032)
- 1.4.1 Global Digital Therapeutics Platforms Market Size by Region (2021-2026)
- 1.4.2 Global Digital Therapeutics Platforms Market Size by Region (2027-2032)
- 1.5 Key Regions Digital Therapeutics Platforms Market Size (2021-2032)
- 1.5.1 North America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
- 1.5.4 South America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
2 Digital Therapeutics Platforms Market by Type
- 2.1 Type Introduction
- 2.1.1 Chronic Disease Digital Therapeutics
- 2.1.2 Psychiatric Disorders Digital Therapeutics
- 2.1.3 Quit Smoking Digital Therapeutics
- 2.1.4 Sleep Disorders and Respiratory Diseases Digital Therapeutics
- 2.1.5 Others
- 2.2 Global Digital Therapeutics Platforms Market Size by Type
- 2.2.1 Global Digital Therapeutics Platforms Market Size Overview by Type (2021-2032)
- 2.2.2 Global Digital Therapeutics Platforms Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Digital Therapeutics Platforms Market Size Forecasted by Type (2027-2032)
- 2.3 Global Digital Therapeutics Platforms Market Size by Regions
- 2.3.1 North America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
3 Digital Therapeutics Platforms Market by Application
- 3.1 Type Introduction
- 3.1.1 Enterprise
- 3.1.2 Personal
- 3.2 Global Digital Therapeutics Platforms Market Size by Application
- 3.2.1 Global Digital Therapeutics Platforms Market Size Overview by Application (2021-2032)
- 3.2.2 Global Digital Therapeutics Platforms Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Digital Therapeutics Platforms Market Size Forecasted by Application (2027-2032)
- 3.3 Global Digital Therapeutics Platforms Market Size by Regions
- 3.3.1 North America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Digital Therapeutics Platforms Industry Trends
- 4.2 Digital Therapeutics Platforms Industry Drivers
- 4.3 Digital Therapeutics Platforms Industry Opportunities and Challenges
- 4.4 Digital Therapeutics Platforms Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Digital Therapeutics Platforms Revenue (2021-2026)
- 5.2 Global Digital Therapeutics Platforms Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Digital Therapeutics Platforms Key Company Headquarters & Area Served
- 5.4 Global Digital Therapeutics Platforms Company, Product Type & Application
- 5.5 Global Digital Therapeutics Platforms Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Digital Therapeutics Platforms Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Digital Therapeutics Platforms Players Market Share by Revenue in 2025
- 5.6.3 2025 Digital Therapeutics Platforms Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Akili Interactive
- 6.1.1 Akili Interactive Company Information
- 6.1.2 Akili Interactive Business Overview
- 6.1.3 Akili Interactive Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
- 6.1.5 Akili Interactive Recent Developments
- 6.2 DarioHealth
- 6.2.1 DarioHealth Company Information
- 6.2.2 DarioHealth Business Overview
- 6.2.3 DarioHealth Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
- 6.2.5 DarioHealth Recent Developments
- 6.3 Teladoc Health
- 6.3.1 Teladoc Health Company Information
- 6.3.2 Teladoc Health Business Overview
- 6.3.3 Teladoc Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
- 6.3.5 Teladoc Health Recent Developments
- 6.4 Voluntis
- 6.4.1 Voluntis Company Information
- 6.4.2 Voluntis Business Overview
- 6.4.3 Voluntis Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
- 6.4.5 Voluntis Recent Developments
- 6.5 Sidekick Health
- 6.5.1 Sidekick Health Company Information
- 6.5.2 Sidekick Health Business Overview
- 6.5.3 Sidekick Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
- 6.5.5 Sidekick Health Recent Developments
- 6.6 WellDoc
- 6.6.1 WellDoc Company Information
- 6.6.2 WellDoc Business Overview
- 6.6.3 WellDoc Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
- 6.6.5 WellDoc Recent Developments
- 6.7 Talkspace
- 6.7.1 Talkspace Company Information
- 6.7.2 Talkspace Business Overview
- 6.7.3 Talkspace Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
- 6.7.5 Talkspace Recent Developments
- 6.8 CogniFit
- 6.8.1 CogniFit Company Information
- 6.8.2 CogniFit Business Overview
- 6.8.3 CogniFit Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
- 6.8.5 CogniFit Recent Developments
- 6.9 Tata Elxsi
- 6.9.1 Tata Elxsi Company Information
- 6.9.2 Tata Elxsi Business Overview
- 6.9.3 Tata Elxsi Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
- 6.9.5 Tata Elxsi Recent Developments
- 6.10 Mahalo Health
- 6.10.1 Mahalo Health Company Information
- 6.10.2 Mahalo Health Business Overview
- 6.10.3 Mahalo Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
- 6.10.5 Mahalo Health Recent Developments
- 6.11 2Morrow
- 6.11.1 2Morrow Company Information
- 6.11.2 2Morrow Business Overview
- 6.11.3 2Morrow Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
- 6.11.5 2Morrow Recent Developments
- 6.12 Omada Health
- 6.12.1 Omada Health Company Information
- 6.12.2 Omada Health Business Overview
- 6.12.3 Omada Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
- 6.12.5 Omada Health Recent Developments
- 6.13 Click Therapeutics
- 6.13.1 Click Therapeutics Company Information
- 6.13.2 Click Therapeutics Business Overview
- 6.13.3 Click Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
- 6.13.5 Click Therapeutics Recent Developments
- 6.14 Orexo
- 6.14.1 Orexo Company Information
- 6.14.2 Orexo Business Overview
- 6.14.3 Orexo Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
- 6.14.5 Orexo Recent Developments
- 6.15 ResMed
- 6.15.1 ResMed Company Information
- 6.15.2 ResMed Business Overview
- 6.15.3 ResMed Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
- 6.15.5 ResMed Recent Developments
- 6.16 Virta Health
- 6.16.1 Virta Health Company Information
- 6.16.2 Virta Health Business Overview
- 6.16.3 Virta Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
- 6.16.5 Virta Health Recent Developments
- 6.17 Bifourmis
- 6.17.1 Bifourmis Company Information
- 6.17.2 Bifourmis Business Overview
- 6.17.3 Bifourmis Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
- 6.17.5 Bifourmis Recent Developments
- 6.18 SilverCloud (Amwell)
- 6.18.1 SilverCloud (Amwell) Company Information
- 6.18.2 SilverCloud (Amwell) Business Overview
- 6.18.3 SilverCloud (Amwell) Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
- 6.18.5 SilverCloud (Amwell) Recent Developments
- 6.19 Noom
- 6.19.1 Noom Company Information
- 6.19.2 Noom Business Overview
- 6.19.3 Noom Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Noom Digital Therapeutics Platforms Product Portfolio
- 6.19.5 Noom Recent Developments
- 6.20 Big Health
- 6.20.1 Big Health Company Information
- 6.20.2 Big Health Business Overview
- 6.20.3 Big Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
- 6.20.5 Big Health Recent Developments
- 6.21 Kaia Health
- 6.21.1 Kaia Health Company Information
- 6.21.2 Kaia Health Business Overview
- 6.21.3 Kaia Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
- 6.21.5 Kaia Health Recent Developments
- 6.22 Cognoa
- 6.22.1 Cognoa Company Information
- 6.22.2 Cognoa Business Overview
- 6.22.3 Cognoa Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
- 6.22.5 Cognoa Recent Developments
- 6.23 Headspace Health
- 6.23.1 Headspace Health Company Information
- 6.23.2 Headspace Health Business Overview
- 6.23.3 Headspace Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
- 6.23.5 Headspace Health Recent Developments
- 6.24 CureApp
- 6.24.1 CureApp Company Information
- 6.24.2 CureApp Business Overview
- 6.24.3 CureApp Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
- 6.24.5 CureApp Recent Developments
- 6.25 Calm Health
- 6.25.1 Calm Health Company Information
- 6.25.2 Calm Health Business Overview
- 6.25.3 Calm Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
- 6.25.5 Calm Health Recent Developments
- 6.26 Riva Health
- 6.26.1 Riva Health Company Information
- 6.26.2 Riva Health Business Overview
- 6.26.3 Riva Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
- 6.26.5 Riva Health Recent Developments
- 6.27 Sweetch-Health
- 6.27.1 Sweetch-Health Company Information
- 6.27.2 Sweetch-Health Business Overview
- 6.27.3 Sweetch-Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
- 6.27.5 Sweetch-Health Recent Developments
- 6.28 Lark Health
- 6.28.1 Lark Health Company Information
- 6.28.2 Lark Health Business Overview
- 6.28.3 Lark Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
- 6.28.5 Lark Health Recent Developments
- 6.29 Vida Health
- 6.29.1 Vida Health Company Information
- 6.29.2 Vida Health Business Overview
- 6.29.3 Vida Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
- 6.29.5 Vida Health Recent Developments
- 6.30 Mahana Therapeutics
- 6.30.1 Mahana Therapeutics Company Information
- 6.30.2 Mahana Therapeutics Business Overview
- 6.30.3 Mahana Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
- 6.30.5 Mahana Therapeutics Recent Developments
- 6.31 Blue Note Therapeutics
- 6.31.1 Blue Note Therapeutics Company Information
- 6.31.2 Blue Note Therapeutics Business Overview
- 6.31.3 Blue Note Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
- 6.31.5 Blue Note Therapeutics Recent Developments
- 6.32 Lyra Health
- 6.32.1 Lyra Health Company Information
- 6.32.2 Lyra Health Business Overview
- 6.32.3 Lyra Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
- 6.32.5 Lyra Health Recent Developments
- 6.33 Modern Health
- 6.33.1 Modern Health Company Information
- 6.33.2 Modern Health Business Overview
- 6.33.3 Modern Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
- 6.33.5 Modern Health Recent Developments
- 6.34 Canary Health
- 6.34.1 Canary Health Company Information
- 6.34.2 Canary Health Business Overview
- 6.34.3 Canary Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
- 6.34.5 Canary Health Recent Developments
- 6.35 Virgin Pulse
- 6.35.1 Virgin Pulse Company Information
- 6.35.2 Virgin Pulse Business Overview
- 6.35.3 Virgin Pulse Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
- 6.35.5 Virgin Pulse Recent Developments
- 6.36 Slanhealth
- 6.36.1 Slanhealth Company Information
- 6.36.2 Slanhealth Business Overview
- 6.36.3 Slanhealth Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
- 6.36.5 Slanhealth Recent Developments
- 6.37 Best Covered
- 6.37.1 Best Covered Company Information
- 6.37.2 Best Covered Business Overview
- 6.37.3 Best Covered Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
- 6.37.5 Best Covered Recent Developments
- 6.38 Dami and Xiaomi
- 6.38.1 Dami and Xiaomi Company Information
- 6.38.2 Dami and Xiaomi Business Overview
- 6.38.3 Dami and Xiaomi Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
- 6.38.5 Dami and Xiaomi Recent Developments
- 6.39 WeiMai
- 6.39.1 WeiMai Company Information
- 6.39.2 WeiMai Business Overview
- 6.39.3 WeiMai Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
- 6.39.5 WeiMai Recent Developments
- 6.40 Jianhai Tech
- 6.40.1 Jianhai Tech Company Information
- 6.40.2 Jianhai Tech Business Overview
- 6.40.3 Jianhai Tech Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
- 6.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
- 6.40.5 Jianhai Tech Recent Developments
7 North America
- 7.1 North America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 7.3 North America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 8.3 Europe Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 10.3 South America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst